Investing

Lantheus : LNTH

LNTH

Stock Data

$85.50

$0.88 (1.04%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Lantheus Holdings Inc specializes in creating advanced diagnostic and therapeutic products that help doctors diagnose and treat diseases such as heart conditions, cancer, and more. Its portfolio includes DEFINITY for ultrasound exams, TechneLite for nuclear medicine, and innovative agents like PYLARIFY for prostate cancer imaging. Lantheus also explores cutting-edge technologies such as artificial intelligence to enhance disease detection and treatment. With collaborations across the healthcare industry, Lantheus is committed to improving patient outcomes through science. Founded in 1956, the company is headquartered in Bedford, Massachusetts.